Home›Search›Tromboz, Gemostaz i Reologiya

Tromboz, Gemostaz i Reologiya

Hemostasis and Rheology LLC · Russian Federation · Est. 2000

ISSN2078-1008

SJR Q3✓ Scopus / SJR

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 75% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.178

H-Indexi

SNIPi

0.155

Total Worksi

448

Total Citationsi

242

2yr Mean Citednessi

0.11

Open Impact Factor alternative

Aims & Scope

Subject areas: Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Biochemistry (medical); Hematology; Physiology (medical).

General Information

Country / RegionRussian Federation

Primary Language—

1st Year Published2000

Annual Volume~ 44 articles / year

StatusActive (last: 2025)

Total Publications448

Region🌍 Global South

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

4/11 · 36%

✅

Do you know the journal / publisher?

Hemostasis and Rheology LLC

❌

Does the journal have a website?

No URL

✅

Is the ISSN verified?

2078-1008

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q3

Biochemistry (medical)Q4

HematologyQ4

Physiology (medical)Q4

Subject Classification

Scopus Categories

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Physiology (medical)HematologyBiochemistry (medical)

Research Topics (OpenAlex)

Neurological Disorders and TreatmentsVenous Thromboembolism Diagnosis and ManagementHemophilia Treatment and ResearchBlood properties and coagulationLegal and Regulatory AnalysisHealthcare Systems and Public HealthLinguistic, Cultural, and Literary StudiesMilitary Technology and StrategiesCOVID-19 Clinical Research StudiesHuman Health and Disease

Frequently asked questions about Tromboz, Gemostaz i Reologiya

Is Tromboz, Gemostaz i Reologiya a predatory journal?

PubScope has no integrity flags on record for Tromboz, Gemostaz i Reologiya: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Tromboz, Gemostaz i Reologiya?

Tromboz, Gemostaz i Reologiya is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.178.

Is Tromboz, Gemostaz i Reologiya indexed in Scopus and Web of Science?

Tromboz, Gemostaz i Reologiya is indexed in Scopus.

What is the aims and scope of Tromboz, Gemostaz i Reologiya?